Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Actym Therapeutics Inc. has 2 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 2 distinct examiners and 2 distinct art units, giving each matter a separate examination setting.
JACKSON-TONGUE, LAKIA J is the busiest examiner, with 1 pending matter. The small docket favors direct case-level review, with no examiner or art-unit concentration to support a broader prosecution pattern.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JACKSON-TONGUE, LAKIA J | 1 | 68.8% | +21.1% |
| EDGINGTONGIORDANO, FRANCESCA | 1 | 72.1% | +29.6% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19214739 | ENGINEERED IMMUNOSTIMULATORY BACTERIAL STRAINS AND USES THEREOF | JACKSON-TONGUE, LAKIA J | — |
| 17569290 | IMMUNOSTIMULATORY BACTERIA-BASED VACCINES, THERAPEUTICS, AND RNA DELIVERY PLATFORMS | EDGINGTONGIORDANO, FRANCESCA | — |
| Art Unit | Apps |
|---|---|
| 1645 | 1 |
| 1643 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19214739 | ENGINEERED IMMUNOSTIMULATORY BACTERIAL STRAINS AND USES THEREOF | JACKSON-TONGUE, LAKIA J | 1645 | §112DP | Non-Final OA | — | Pending | May 21, 2025 |
| 17569290 | IMMUNOSTIMULATORY BACTERIA-BASED VACCINES, THERAPEUTICS, AND RNA DELIVERY PLATFORMS | EDGINGTONGIORDANO, FRANCESCA | 1643 | §112DP | Non-Final OA | — | Pending | Jan 05, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialActym Therapeutics Inc. has 2 pending office actions as of November 2026, spread across 2 art units and 2 examiners.
Lakia J Jackson-Tongue has the most, with 1 of Actym Therapeutics Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.